| Lipid-lowering background therapy, n (%) | 14 (70) | 2 (40) |
| Statins, n (%) | 12 (85) | 2 (40) |
| Fibrate, n (%) | 2 (14) | 0 |
| Ezetimibe, n (%) | 1 (0.7) | 0 |
α-GI, α-glucosidase inhibitor; ACEI, ACE inhibitor; ARB, angiotensin II receptor blocker; DPP-4, dipeptidyl peptidase-4; RAS, renin–angiotensin system; SGLT2, sodium-glucose cotransporter 2; SU, sulfonylurea.